Share this article
Share this article
ResearchAndMarkets.com's offering.
The global neurovascular devices market is growing expressively, was valued at US$ 2203.9 Mn in 2020 and expected to reach US$ 3853.1 Mn by 2029. Increasing demand for minimally invasive procedures, growing commonness of neurovascular disorders and stroke, rapid new product development and commercialization drive the overall neurovascular devices market growth. Technological evolution in stenting technique, coiling procedure technique, cerebral angiography technique, and flow disruption technique would also drive the overall market.
Cerebral balloon angioplasty & stenting technology segment is expected to register higher growth by the end of 2029
The global sale of neurovascular devices is expanding significantly, mainly in the Asia Pacific, MEA and Europe. Availability of a wide range of neurovascular devices, mainly in the aneurysm coiling and embolization devices segment enable professionals to meet the active demand. Other major factors driving the growth include product expansion for carotid stents and balloon catheters among neurologists, increasing admissions of patients suffering from atherosclerosis or ischemic strokes, development in the nature and number of multispecialty hospitals and neurosurgical centers along with enhanced reimbursement structure across developing nations.